PFE logo

Pfizer (PFE) Company Overview

Profile

Full Name:

Pfizer Inc.

Sector:

Healthcare

Industry:

Drug Manufacturers - General

Country:

United States

IPO:

June 1, 1972

Indexes:

S&P 500

Website:

http://www.pfizer.com

Description:

Pfizer Inc. is one of the leading international biopharmaceutical companies, founded in New York in 1849. Every year, Pfizer's medicines and vaccines help people around the world fight many diseases and lead a healthy lifestyle. The company's product portfolio includes medicines, including vaccines, as well as well-known vitamins and other products that promote health maintenance. The IH segment focuses on the development and commercialization of medicines and vaccines for internal diseases, oncology, inflammation and immunology, morbidity, and healthcare. The EH segment is involved in the development and supply of proprietary generics, non-patented sterile injectable drugs, biosimilars, and certain proprietary products, including anti-infectives.

Key Details

Price

$26.66

Market Cap

$151.09 B(Mega cap)

Last Dividend

$0.43

TTM Dividend Yield

6.34%

Annual Revenue

$63.63 B(+6.84% YoY)

Annual EPS

$1.41(+281.08% YoY)

PE Ratio

18.91

Annual ROE

9.03%

Annual Debt To Equity

0.72

Beta

-

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Feb 4, 2025

Recent annual earnings:

Feb 4, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jan 24, 2025
Splits

Next split:

N/A

Recent split:

Nov 17, 2020

Analyst ratings

Recent major analysts updates

Feb 10, 25 Guggenheim
Buy
Feb 5, 25 UBS
Neutral
Jan 28, 25 Citigroup
Neutral
Jan 8, 25 UBS
Neutral
Dec 18, 24 Truist Securities
Buy
Dec 11, 24 Guggenheim
Buy
Nov 15, 24 Wolfe Research
Underperform
Oct 30, 24 Morgan Stanley
Equal-Weight
Oct 25, 24 Cantor Fitzgerald
Overweight
Oct 23, 24 Cantor Fitzgerald
Overweight

Screeners with PFE included

Growing Shares Outstanding
US stocks
High Piotroski score stocks
S&P 500 companies earnings calendar
Stocks below SMA 200
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
S&P 500 companies
Stocks below analysts price target

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$26.66
PFE price is $26.66

Price All-time High

$61.25
PFE price is currently -56.47% below its historical high of $61.25

Price Analysts Target

$30.00
PFE price is currently -11.13% lower than the consensus analysts' forecast

Price Most Recent Change

+1.83%
PFE price was up +1.83% on Mar 8, 2025

Price YTD Change

+0.76%
PFE price is up +0.76% since January 1st

Price 3-Year Change

-44.44%
PFE price is down -44.44% over the past 3 years

Market cap

Market Cap

$151.09 B
PFE market capitalization is $151.09 billion

Market Cap 3-Year Change

-44.24%
PFE market capitalization is down -44.24% over the past 3 years

Market Cap All-time High

$343.79 B
PFE market capitalization is currently -56.05% below its historical high of $343.79 billion

Market Cap Sector Rank

98.93%
PFE market capitalization is higher than 98.93% of companies in Healthcare sector

Technical

Beta

-
PFE beta value is unknown

200-day SMA

$27.76
PFE price is currently -3.95% below its 200-day simple moving average

14-day RSI

-
PFE 14-day relative strength index value is unknown

30-day Relative Volume

1.17
PFE 30-day relative volume is 1.17

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.43
PFE last dividend was $0.43 per share, with an ex-dividend date of January 24, 2025

Next Dividend

-
PFE next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$1.68
PFE annual dividend per share is $1.68

Annual Dividend Per Share Sector Rank

61.18%
PFE annual dividend per share is higher than 61.18% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+2.44%
PFE annual dividend per share is up +2.44% year-on-year

Annual Dividend Per Share 3-Year Change

+7.69%
PFE annual dividend per share is up +7.69% over the past 3 years

Dividend yield

Annual Dividend Yield

6.30%
PFE annual dividend yield is 6.30%

Annual Dividend Yield Sector Rank

90.24%
PFE annual dividend yield is higher than 90.24% of companies in Healthcare sector

Other

Annual Payout Ratio

118.44%
PFE annual payout ratio is 118.44%

Annual Dividends Paid

$9.51 B
PFE annual dividends paid is $9.51 billion

Annual FCF

$9.84 B
PFE annual free cash flow is $9.84 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$63.63 B
PFE annual revenue is $63.63 billion

Annual Revenue Analysts Estimate

$62.94 B
PFE annual revenue is currently +1.09% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+6.84%
PFE annual revenue is up +6.84% year-on-year

Annual Revenue Sector Rank

98.53%
PFE annual revenue is higher than 98.53% of companies in Healthcare sector

Profit

Annual Gross Profit

$45.78 B
PFE annual gross profit is $45.78 billion

Annual Gross Margin

71.94%
PFE annual gross profit margin is 71.94%

Annual Operating Profit

$14.94 B
PFE annual operating income is $14.94 billion

Annual Operating Margin

23.48%
PFE annual operating profit margin is 23.48%

Annual Net Income

$8.03 B
PFE annual net profit is $8.03 billion

Annual Net Margin

12.62%
PFE annual net profit margin is 12.62%

EPS

Annual EPS

$1.41
PFE annual earnings per share is $1.41

Annual EPS Analysts Estimate

$2.95
PFE annual earnings per share is currently -52.17% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+281.08%
PFE annual earnings per share is up +281.08% year-on-year

Annual EPS Sector Rank

90.63%
PFE annual earnings per share is higher than 90.63% of companies in Healthcare sector

ROA & ROE

Annual ROA

3.65%
PFE annual return on assets is 3.65%

Annual ROE

9.03%
PFE annual return on equity is 9.03%

EBIT & EBITDA

Annual EBIT

$11.11 B
PFE annual earnings before interest & taxes is $11.11 billion

Annual EBITDA

$16.40 B
PFE annual EBITDA is $16.40 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

18.91
PFE price to earnings ratio is 18.91

PE Ratio Sector Rank

33.99%
PFE price to earnings ratio is higher than 33.99% of companies in Healthcare sector

PB Ratio

PB Ratio

1.71
PFE price to book ratio is 1.71

PB Ratio Sector Rank

55.68%
PFE price to book ratio is higher than 55.68% of companies in Healthcare sector

PS Ratio

PS Ratio

2.37
PFE price to sales ratio is 2.37

PS Ratio Sector Rank

43.68%
PFE price to sales ratio is higher than 43.68% of companies in Healthcare sector

Enterprise value

Enterprise Value

$213.70 B
PFE enterprise value is $213.70 billion

Enterprise Value Sector Rank

99.17%
PFE enterprise value is higher than 99.17% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

12.08
PFE EV/EBITDA is 12.08

EV/EBITDA Sector Rank

84.15%
PFE EV/EBITDA is higher than 84.15% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.17
PFE annual current ratio is 1.17

Annual Quick Ratio

0.92
PFE annual quick ratio is 0.92

Leverage

Annual Debt To Equity

0.72
PFE annual debt to equity ratio is 0.72

Annual Interest Coverage Ratio

3.60
PFE annual interest coverage ratio is 3.60

Risk & Stability

Piotroski F-Score

8
PFE piotroski f-score is 8

Altman Z-Score

2.00
PFE altman z-score is 2.00

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$213.40 B
PFE annual total assets is $213.40 billion

Annual Non Current Assets

$163.04 B
PFE annual long term assets is $163.04 billion

Annual Current Assets

$50.36 B
PFE annual total current assets is $50.36 billion

Annual Cash & Cash Equivalents

$1.04 B
PFE annual cash & cash equivalents is $1.04 billion

Equity

Annual Book Value

$88.20 B
PFE annual book value is $88.20 billion

Annual Working Capital

$7.36 B
PFE annual working capital is $7.36 billion

Liabilities

Annual Total Liabilities

$124.90 B
PFE annual total liabilities is $124.90 billion

Annual Total Long Term Liabilities

$81.90 B
PFE annual total long term liabilities is $81.90 billion

Annual Current Liabilities

$42.99 B
PFE annual total current liabilities is $42.99 billion

Annual Accounts Payable

$5.63 B
PFE annual accounts payable is $5.63 billion

Debt

Annual Total Debt

$63.65 B
PFE annual total debt is $63.65 billion

Annual Total Debt 1-Year Change

-10.16%
PFE annual total debt is down -10.16% year-on-year

Annual Long Term Debt

$56.70 B
PFE annual long term debt is $56.70 billion

Annual Short Term Debt

$6.95 B
PFE annual short term debt is $6.95 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$48.69 B
PFE annual total expenses is $48.69 billion

Annual Operating Expenses

$30.84 B
PFE annual total operating expenses is $30.84 billion

Annual Cost Of Goods Sold

$17.85 B
PFE annual cost of goods sold is $17.85 billion

Annual SGA

$14.73 B
PFE annual SGA is $14.73 billion

Annual D&A

$7.01 B
PFE annual depreciation & amortization is $7.01 billion

Annual Interest Expense

$3.09 B
PFE annual interest expense is $3.09 billion

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$12.74 B
PFE annual cash flow from operations is $12.74 billion

Annual CFO 1-Year Change

+46.48%
PFE annual cash flow from operations is up +46.48% year-on-year

Annual CFI

$2.65 B
PFE annual cash flow from investing activities is $2.65 billion

Annual CFI 1-Year Change

+108.22%
PFE annual cash flow from investing activities is up +108.22% year-on-year

Annual CFF

-$17.14 B
PFE annual cash flow from financing activities is -$17.14 billion

Annual CFF 1-Year Change

-165.76%
PFE annual cash flow from financing activities is down -165.76% year-on-year

Free CashFlow

Annual FCF

$9.84 B
PFE annual free cash flow is $9.84 billion

Annual FCF 1-Year Change

+105.2%
PFE annual free cash flow is up +105.2% year-on-year

CAPEX

Annual CAPEX

$2.91 B
PFE annual capital expenditures is $2.91 billion

Annual CAPEX 1-Year Change

-25.54%
PFE annual capital expenditures is down -25.54% year-on-year

Institutional Ownership

Similar stocks

DHR logo
Danaher (DHR)
SNY logo
Sanofi (SNY)
GILD logo
Gilead Sciences (GILD)
SYK logo
Stryker (SYK)
BSX logo
Boston Scientific (BSX)
AMGN logo
Amgen (AMGN)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
BMY logo
Bristol-Myers Squibb (BMY)
MDT logo
Medtronic (MDT)

FAQ

  • What is the ticker symbol for Pfizer?
  • Does Pfizer pay dividends?
  • What sector is Pfizer in?
  • What industry is Pfizer in?
  • What country is Pfizer based in?
  • When did Pfizer go public?
  • Is Pfizer in the S&P 500?
  • Is Pfizer in the NASDAQ 100?
  • Is Pfizer in the Dow Jones?
  • When was Pfizer's last earnings report?
  • When does Pfizer report earnings?
  • Should I buy Pfizer stock now?

What is the ticker symbol for Pfizer?

The ticker symbol for Pfizer is NYSE:PFE

Does Pfizer pay dividends?

Yes, Pfizer pays dividends. The last payment was $0.43, with an ex-dividend date on January 24, 2025

What sector is Pfizer in?

Pfizer is in the Healthcare sector

What industry is Pfizer in?

Pfizer is in the Drug Manufacturers - General industry

What country is Pfizer based in?

Pfizer is headquartered in United States

When did Pfizer go public?

Pfizer's initial public offering (IPO) was on June 1, 1972

Is Pfizer in the S&P 500?

Yes, Pfizer is included in the S&P 500 index

Is Pfizer in the NASDAQ 100?

No, Pfizer is not included in the NASDAQ 100 index

Is Pfizer in the Dow Jones?

No, Pfizer is not included in the Dow Jones index

When was Pfizer's last earnings report?

Pfizer's most recent earnings report was on Feb 4, 2025

When does Pfizer report earnings?

The next expected earnings date for Pfizer is May 1, 2025

Should I buy Pfizer stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions